跳至主要内容
临床试验/CTRI/2026/04/108224
CTRI/2026/04/108224尚未招募不适用

A Randomized control trial to assess the effectiveness of Comprehensive Care Intervention Program on Integrated Recovery among patient with Multiple Myeloma at AIIMS, New Delhi.

Self1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2026年8月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
Self
入组人数
78
试验地点
1

研究概览

简要总结

This study is a randomized control trial to assess the effectiveness of comprehensive care program intervention on integrated recovery among patient s with multiple myeloma. After screening based on inclusion and exclusion criteria baseline assessment of the participants will be done. Randomization will be done of the enrolled participant into control and experimental group. After randomization control group will receive routine care whereas experimental group will receive comprehensive care intervention along with routine care. Reinforcement of the intervention will be done at 2 week and 4 weeks post intervention. Post intervention assessment will be done at 6 weeks. The findings of this study will help in improving the symptom burden of the disease condition and quality of life of people suffering from multiple myeloma

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 98.00 Year(s)(—)
性别
All

入选标准

  • Age 18 years or above with confirmed diagnosis of multiple myeloma Newly diagnosed patients with multiple myeloma Receiving outpatient care at AIIMS Delhi Able to understand and communicate in Hindi or English Willing to participate in the study.

排除标准

  • Severe cognitive impairment or diagnosed dementia or Severe psychiatric illness Currently hospitalized for acute complications at the time of enrollment Receiving end-of-life care or enrolled in hospice Previously participated in similar kind of studies.

研究者

发起方
Self
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Hema

AIIMS New Delhi

研究点 (1)

Loading locations...

相似试验